HOME >> BIOLOGY >> NEWS
Novel flu vaccine shows promise in mice

PHILADELPHIA - Globally, the influenza virus, or flu, is thought to cause between three and five million cases of severe illness and between 250,000 and 500,000 deaths annually, according to the World Health Organization. New strains of the virus emerge each year, so that the U.S. Centers for Disease Control and other public health services must produce and distribute a new vaccine against the new flu strains each year. And each year, people seeking to avoid a flu infection must arrange to receive a flu shot - rarely a pleasant experience - from their doctor or other health-care provider. Also, the effectiveness of the vaccine is known to decline in the elderly, a population for whom flu infections can be particularly dangerous.

A new prototype vaccine developed by researchers at The Wistar Institute, however, might be able to protect recipients not only against this year's strains of the virus, but also against those yet to come, possibly eliminating the need for an annual shot. In fact, because the vaccine would be administered as a nasal spray, it could eliminate the need for a shot of any kind. A report on the new findings appears in the June 2 issue of the journal Vaccine.

"Current vaccines are quite effective, but they are based on regions of the virus that mutate rapidly, so health officials are constantly faced with the problem of updating the vaccines," says Walter Gerhard, M.D., senior author on the Vaccine report and a professor in the immunology program at The Wistar Institute. "A vaccine directed against a more stable region of the virus would offer important public-health advantages, and this is what we are hoping to be able to develop."

Current flu vaccines trigger an immune response to a pair of prominent viral-coat proteins that mutate constantly, which is the reason last year's flu vaccine is ineffective against this year's flu strains. The experimental vaccine contains an engineered peptide that mimics a third, smaller vira
'"/>

Contact: Franklin Hoke
hoke@wistar.upenn.edu
215-898-3716
The Wistar Institute
27-May-2003


Page: 1 2 3

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
3. Novel approaches to current cellular therapies continue progress toward disease prevention
4. Novel therapies show promise against myeloid leukemia
5. Novel sensors help clear the air
6. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
7. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
8. Novel therapeutic target identified in fight against Rheumatoid Arthritis
9. Novel bacterium detoxifies chlorinated pollutants
10. Novel gene therapy on the horizon, says Brenner Childrens Hospital pediatrician
11. Novel method identifies hidden genes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/18/2019)... (PRWEB) , ... March 18, 2019 , ... ... cost-effective, but also successfully leverages the patient perspective and improves participation by better ... is one way of involving the patient in the entire process from development ...
(Date:3/13/2019)... N.J. (PRWEB) , ... March 13, 2019 , ... ... for the Pharmaceutical, Biotechnology and Medical Device Industries, is excited to announce that it ... in early February 2019 and the newly installed and highly experienced management team ...
(Date:3/9/2019)... ... March 07, 2019 , ... A firm believer in causes ... & Lymphoma Society (LLS). This donation will help fund not only research to find ... families. , “We are always on the lookout for ways to make a ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... , ... March 19, 2019 , ... ... Inc. (Konica Minolta) today announced the formation of their inaugural Scientific Advisory Board. ... of precision medicine that takes into account individual variability in genes, environment, and ...
(Date:3/18/2019)... BARBARA, Calif. (PRWEB) , ... March 18, 2019 , ... ... have partnered together to develop solutions that allow life science companies to easily comply ... requirements. USDM’s Cloud Assurance ™ is a managed service delivering end-to-end GxP compliance ...
(Date:3/14/2019)... ... March 14, 2019 , ... Open ... themed “Navigating the Full Spectrum of Case Management,” continues as CMSA makes plans ... conference is the only case management industry conference serving the educational and networking ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... solution for preclinical research organizations. It is a low code, GDPR/21 CFR ... and facilities, innovative technology-driven automated data capture and seamless data and information ...
Breaking Biology Technology:
Cached News: